Characterization of a novel BCHE "silent" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.
about
Pharmacogenetics and anaesthetic drugs: Implications for perioperative practicePharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamicsPressure-induced molten globule state of human acetylcholinesterase: structural and dynamical changes monitored by neutron scattering.The pharmacogenetics of medications used in general anesthesia.Delipidation of Plasma Has Minimal Effects on Human Butyrylcholinesterase.
P2860
Characterization of a novel BCHE "silent" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Characterization of a novel BC ...... nged apnea with suxamethonium.
@ast
Characterization of a novel BC ...... nged apnea with suxamethonium.
@en
type
label
Characterization of a novel BC ...... nged apnea with suxamethonium.
@ast
Characterization of a novel BC ...... nged apnea with suxamethonium.
@en
prefLabel
Characterization of a novel BC ...... nged apnea with suxamethonium.
@ast
Characterization of a novel BC ...... nged apnea with suxamethonium.
@en
P2093
P2860
P1433
P1476
Characterization of a novel BC ...... onged apnea with suxamethonium
@en
P2093
Aurore Bousquet
Franck Ceppa
Herve Delacour
Isabelle Mabboux
Lawrence M Schopfer
Oksana Lockridge
P2860
P304
P356
10.1371/JOURNAL.PONE.0101552
P407
P577
2014-07-23T00:00:00Z